Oncosil Medical Ltd has released a press release.
Appendix 4C and Quarterly update
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- First OncoSil Device Implantation procedure completed
- Specialised Therapeutics Australia supporting OncoSil study
- US IRB Approval, MD Anderson Cancer Centre
- UK Central Ethics Approval
- First subject recruited
Later from OncoSil Medical
- Second subject recruited at Monash Health Melbourne
- CE Mark & Quarterly Activity Update
- First UK subject recruited
- Appendix 4E - Preliminary Final Report 30 June 2017
- Progress update on Global Pancreatic Cancer Clinical Study
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical